Griffith & Werner, Inc. Abb Vie Inc. Transaction History
Griffith & Werner, Inc.
- $161 Billion
- Q1 2025
A detailed history of Griffith & Werner, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Griffith & Werner, Inc. holds 11,447 shares of ABBV stock, worth $2.23 Million. This represents 1.49% of its overall portfolio holdings.
Number of Shares
11,447
Previous 10,826
5.74%
Holding current value
$2.23 Million
Previous $1.92 Billion
24.67%
% of portfolio
1.49%
Previous 1.27%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
4,184Shares Held
1.29BCall Options Held
17.1MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA173MShares$33.8 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.5 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10.1 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.74 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $345B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...